{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T16:20:54Z","timestamp":1792686054625,"version":"4.5.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.4158\/ep161350.or","type":"journal-article","created":{"date-parts":[[2016,8,19]],"date-time":"2016-08-19T12:22:03Z","timestamp":1471609323000},"page":"1336-1342","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Gender Influences the Clinical Presentation and Long-Term Outcome of Graves Disease"],"prefix":"10.1016","volume":"22","author":[{"given":"Flavia","family":"Magri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Zerbini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margherita","family":"Gaiti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Capelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Ragni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Rotondi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Chiovato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.4158\/EP161350.OR_bb0010","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1056\/NEJMcp0801880","article-title":"Clinical practice. Graves' disease","volume":"358","author":"Brent","year":"2008","journal-title":"N Engl J Med"},{"key":"10.4158\/EP161350.OR_bb0015","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1089\/thy.1991.1.129","article-title":"Differences and similarities in the diagnosis and treatment of Graves' disease in Europe, Japan and the United States","volume":"1","author":"Wartofsky","year":"1991","journal-title":"Thyroid"},{"key":"10.4158\/EP161350.OR_bb0020","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1001\/jama.2015.16535","article-title":"Management of Graves disease: a review","volume":"314","author":"Burch","year":"2015","journal-title":"JAMA"},{"key":"10.4158\/EP161350.OR_bb0025","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1089\/thy.2015.0195","article-title":"Outcomes in relapsed Graves' disease patients following radioiodine or prolonged low dose of methimazole treatment","volume":"25","author":"Villagelin","year":"2015","journal-title":"Thyroid"},{"key":"10.4158\/EP161350.OR_bb0030","first-page":"CD003420","article-title":"Antithyroid drug regimen for treating Graves' hyperthyroidism","author":"Abraham","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"10.4158\/EP161350.OR_bb0035","first-page":"2986","article-title":"Graves' hyperthyroidism: treatment with antithyroid drugs, surgery, or radioiodine--a prospective, randomized study. Thyroid Study Group","volume":"81","author":"T\u00f6rring","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP161350.OR_bb0040","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1089\/thy.2010.1654","article-title":"Treatment of Graves' disease with antithyroid drug: current perspectives","volume":"20","author":"Boelaert","year":"2010","journal-title":"Thyroid"},{"key":"10.4158\/EP161350.OR_bb0045","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1089\/thy.1997.7.369","article-title":"Clinical features of patients with Graves' disease undergoing remission after antithyroid drug treatment","volume":"7","author":"Vitti","year":"1997","journal-title":"Thyroid"},{"key":"10.4158\/EP161350.OR_bb0050","first-page":"1038","article-title":"Age and gender predict the outcome and treatment for Graves' hyperthyroidism","volume":"85","author":"Allahabadia","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP161350.OR_bb0055","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1046\/j.1365-2796.1998.00320.x","article-title":"Clinical, biochemical and immunological characteristics of relapsers and non-relapsers of thyrotoxicosis treated with anti-thyroid drugs","volume":"244","author":"Chowdhury","year":"1998","journal-title":"J Intern Med"},{"key":"10.4158\/EP161350.OR_bb0060","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1111\/j.1365-2265.2007.02933.x","article-title":"Patients with severe Graves' ophthalmopathy have a higher risk of relapsing hyperthyroidism and are unlikely to remain in remission","volume":"67","author":"Eckstein","year":"2007","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.4158\/EP161350.OR_bb0065","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1507\/endocrj.K06-069","article-title":"Prognostic value of thyrotropin receptor antibodies (TRAb) in Graves' disease: a 120 months prospective study","volume":"54","author":"Cappelli","year":"2007","journal-title":"Endocr J"},{"key":"10.4158\/EP161350.OR_bb0070","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1089\/thy.2006.16.295","article-title":"Serum thyrotropin receptor antibodies concentrations in patients with Graves' disease before, at the end of methimazole treatment, and after drug withdrawal: evidence that the activity of thyrotropin receptor antibody and\/or thyroid response modify during","volume":"16","author":"Carella","year":"2006","journal-title":"Thyroid"},{"key":"10.4158\/EP161350.OR_bb0075","doi-asserted-by":"crossref","first-page":"4873","DOI":"10.1210\/jc.2006-1402","article-title":"Influences of age, gender, smoking, and family history on autoimmune thyroid disease phenotype","volume":"91","author":"Manji","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP161350.OR_bb0080","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1055\/s-0035-1555759","article-title":"Outcome prediction of treatment of Graves' hyperthyroidism with antithyroid drugs","volume":"47","author":"Piantanida","year":"2015","journal-title":"Horm Metab Res"},{"key":"10.4158\/EP161350.OR_bb0085","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1530\/EJE-07-0666","article-title":"Consensus statement of the European Group on Graves' orbitopathy (EUGOGO) on management of GO","volume":"158","author":"Bartalena","year":"2008","journal-title":"Eur J Endocrinol"},{"key":"10.4158\/EP161350.OR_bb0090","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1089\/thy.1997.7.369","article-title":"Clinical features of patients with Graves' disease undergoing remission after antithyroid drug treatment","volume":"7","author":"Vitti","year":"1997","journal-title":"Thyroid"},{"key":"10.4158\/EP161350.OR_bb0095","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1038\/nrendo.2013.193","article-title":"Diagnosis and management of Graves disease: a global overview","volume":"9","author":"Bartalena","year":"2013","journal-title":"Nat Rev Endocrinol"},{"key":"10.4158\/EP161350.OR_bb0100","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1210\/jc.2012-3873","article-title":"Prevalence and natural history of Graves'orbitopathy in a large series of patients with newly diagnosed Graves' hyperthyrodism seen at a single center","volume":"98","author":"Tanda","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP161350.OR_bb0105","doi-asserted-by":"crossref","first-page":"204","DOI":"10.3413\/Nukmed-0739-15-04","article-title":"Etiopathogenesis of Basedow's disease. Trends and current aspects","volume":"54","author":"Leporati","year":"2015","journal-title":"Nuklearmedizin"},{"key":"10.4158\/EP161350.OR_bb0110","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1136\/ard.54.1.6","article-title":"Sex hormones, glucocorticoids and autoimmunity: facts and hypotheses","volume":"54","author":"Da Silva","year":"1995","journal-title":"Ann Rheum Dis"},{"key":"10.4158\/EP161350.OR_bb0115","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1530\/EJE-13-0455","article-title":"The relationship between circulating estradiol and thyroid autoimmunity in males","volume":"170","author":"Chailurkit","year":"2013","journal-title":"Eur J Endocrinol"},{"key":"10.4158\/EP161350.OR_bb0120","first-page":"427","article-title":"Independent pretreatment predictors of Graves' disease outcome","volume":"49","author":"Dauk\u0161ien\u0117","year":"2013","journal-title":"Medicina (Kaunas)"},{"key":"10.4158\/EP161350.OR_bb0125","first-page":"689","article-title":"Prospective multicentre study on the prediction of relapse after antithyroid drug treatment in patients with Graves' disease","volume":"120","author":"Schleusener","year":"1989","journal-title":"Acta Endocrinol (Copenh)"},{"key":"10.4158\/EP161350.OR_bb0130","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1507\/endocrj.K06-069","article-title":"Prognostic value of thyrotropin receptor antibodies (TRAb) in Graves' disease: a 120 months prospective study","volume":"54","author":"Cappelli","year":"2007","journal-title":"Endocr J"},{"key":"10.4158\/EP161350.OR_bb0135","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1530\/EJE-13-0811","article-title":"Long-term prognosis after medical treatment of Graves' disease in a northern Swedish population 2000\u20132010","volume":"170","author":"Mohlin","year":"2010","journal-title":"Eur J Endocrinol"},{"key":"10.4158\/EP161350.OR_bb0140","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/00005792-197405000-00001","article-title":"Hyperthyroidism in patients over the age of 60 years","volume":"53","author":"Davis","year":"1974","journal-title":"Clinical features in 85 patients. Medicine (Baltimore)"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20355890?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20355890?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:00:12Z","timestamp":1761516012000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X20355890"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":27,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["S1530891X20355890"],"URL":"https:\/\/doi.org\/10.4158\/ep161350.or","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gender Influences the Clinical Presentation and Long-Term Outcome of Graves Disease","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4158\/EP161350.OR","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}